Becker's Healthcare December 5, 2024
Robert F. Kennedy Jr., nominated to lead HHS under President Donald Trump’s second term, brings a range of healthcare positions that could directly and indirectly influence public health, pharmaceuticals and health systems.
If Mr. Kennedy is confirmed as the secretary of HHS, he would be the 26th leader of the agency. Given HHS’ vast budget of $1.8 trillion in 2024, Mr. Kennedy’s leadership could shape significant policy directions, resource allocation and more. He would oversee critical agencies like the CDC, FDA, CMS and NIH, shaping policies that impact millions of Americans.
Below are key aspects of his healthcare views and potential implications.
1. Mr. Kennedy has prioritized addressing chronic disease, which accounts for over $1 trillion in annual U.S....
Today's Sponsors
Today's Sponsor